2-piperazin-1-yl-4h-1,3-benzothiazin-4-one derivatives and their use for the treatment of mammalian infections
The present invention relates to new 2-piperazin-1-yl-4H-1,3-benzothiazin- 4-one derivatives and their use for the treatment of mammalian infections caused by bacteria, especially diseases like tuberculosis (TB), Buruli ulcer and leprosy that result from infection with closely related mycobacteria. (I).
45349249
Alternative title(s) : (de) 2-piperazin-1-yl-4h-1,3-benzothiazin-4-on-derivate und ihre verwendung zur behandlung von infektionen bei säugetieren (fr) Dérivés de 2-pipérazin-1-yl-4h-1,3-benzothiazin-4-one et leur utilisation dans le traitement des infections chez les mammifères
TTO:6.1036
Patent number | Country code | Kind code | Date issued |
BR112013012280 | BR | B1 | 2022-01-04 |
BR112013012280 | BR | A2 | 2020-09-01 |
PL2640712 | PL | T3 | 2019-03-29 |
HUE040152 | HU | T2 | 2019-02-28 |
ES2690728 | ES | T3 | 2018-11-22 |
TR201815010 | TR | T4 | 2018-11-21 |
LT2640712 | LT | T | 2018-11-12 |
KR101871970 | KR | B1 | 2018-08-02 |
EP2640712 | EP | B1 | 2018-07-11 |
KR101851774 | KR | B1 | 2018-04-25 |
KR20170137211 | KR | A | 2017-12-12 |
CA2817931 | CA | C | 2017-10-31 |
CN107011287 | CN | A | 2017-08-04 |
JP6061346 | JP | B2 | 2017-01-18 |
AU2011330742 | AU | B2 | 2016-10-13 |
GEP201606545 | GE | B | 2016-09-26 |
IL226289 | IL | A | 2016-07-31 |
EA023879 | EA | B1 | 2016-07-29 |
UA109557 | UA | C2 | 2015-09-10 |
US8796264 | US | B2 | 2014-08-05 |
KR20140012956 | KR | A | 2014-02-04 |
ZA201303829 | ZA | B | 2014-01-29 |
JP2013542980 | JP | A | 2013-11-28 |
EA201390639 | EA | A1 | 2013-09-30 |
EP2640712 | EP | A1 | 2013-09-25 |
US2013245007 | US | A1 | 2013-09-19 |
CN103221399 | CN | A | 2013-07-24 |
AU2011330742 | AU | A1 | 2013-06-27 |
CA2817931 | CA | A1 | 2012-05-24 |
WO2012066518 | WO | A1 | 2012-05-24 |